To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Ovarian cancer (OvC) is one of the neoplasms with the highest incidence among women worldwide, with significantly increased mortality. The vast majority of patients are diagnosed in advanced stages of the disease since early stages present unspecific symptoms and inaccurate diagnoses. Currently, not many clinical biomarkers are available to aid in the diagnosis or predict the prognosis of HGSOC. The application of omics approaches on non-invasive samples, such as liquid biopsies, combined with artificial intelligence techniques shows promise, not only for identifying effective biomarkers for prognosis and diagnosis of OvC, but also for decision making. Therefore, our goal is to build a predictor of prognosis for patients diagnosed with ovarian cancer, as well as to identify new biomarkers. MATERIAL AND METHODS: Prognostic groups were defined based on the number of years of overall survival and their vital status: Patients with less than 3 years of survival and with Dead status were allocated as the group with poor prognosis and patients with ≥ 3 years were considered as a good prognosis. Based on the miRNA expression data from samples of patients diagnosed with ovarian cancer obtained from the database of The Cancer Genome Atlas (TCGA) project, we applied variable selection methods (FCBF, Cox Univariate Regression, and ElasticNet) to identify relevant predictors. Subsequently, samples were subject to a ten-fold split (outer cross-validation), wherein each 10% split was used as a held-out set, with the remaining 90% used as a training set. Random Forest (RF) classifiers were trained with hyperparameter optimization performed through a grid search with ten-fold internal cross-validation, leading to a total of ten separate AUC (Area Under Curve) values. The mean of these ten values was calculated as a summary AUC metric. RESULTS AND CONCLUSION: After applying the variable selection methods, 47 miRNAs were selected as important for the clinical outcome of patients with OvC. Regarding the performance of the models on the test data set, RF showed excellent metrics: 0.848 AUC (Area Under the Curve); 0.761 sensitivity; 0.771 precision, and with an accuracy of 0.763. Among the miRNAs with greater predictive potential, miRNA-205-5p was considered an excellent predictor by the RF model to classify patients with good or poor prognosis regarding survival. Published studies show that this miRNA has a mechanism of action dependent on tumor cell-derived exosomes and has the ability to regulate angiogenesis in the tumor, thus being a potential therapeutic target for OvC. Furthermore, independently evaluating the miRNAs indicated by the RF model as having the highest predictive potential, miRNA-143-3p showed an AUC of 0.700. Through in vitro experimental studies, authors have already demonstrated that this miRNA acts as a tumor suppressor in ovarian cancer cell lines.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper